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Abstract
A cellular scaffolds derived from Bombyx mori silk fibroin were investigated for their ability to
support functional tissue regeneration in a porcine model of augmentation cystoplasty. Two bi-
layer matrix configurations were fabricated by solvent-casting/salt leaching either alone (Group 1)
or in combination with silk film casting (Group 2) to yield porous foams buttressed by
heterogeneous surface pore occlusions or homogenous silk films, respectively. Bladder
augmentation was performed with each scaffold group (6×6cm2) in juvenile Yorkshire swine for 3
m of implantation. Augmented animals exhibited high rates of survival (Group 1: 5/6, 83%; Group
2: 4/4, 100%) and voluntary voiding over the course of the study period. Urodynamic evaluations
demonstrated mean increases in bladder capacity over pre-operative levels (Group 1: 277%;
Group 2: 153%) which exceeded non surgical control gains (144%) encountered due to animal
growth. Similarly, elevations in bladder compliance were substantially higher in augmented
animals from baseline (Group 1: 357%; Group 2: 147%) in comparison to controls (41%). Gross
tissue evaluations revealed that both matrix configurations supported extensive de novo tissue
formation throughout the entire original implantation site which exhibited ultimate tensile strength
similar to nonsurgical counterparts. Histological and immunohistochemical analyses showed that
both implant groups promoted comparable extents of smooth muscle regeneration and contractile
protein (α-smooth muscle actin and SM22α) expression within defect sites similar to controls.
Parallel evaluations demonstrated the formation of a transitional, multi-layered urothelium with
prominent cytokeratin, uroplakin, and p63 protein expression in both matrix groups. De novo
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innervation and vascularization processes were evident in all regenerated tissues indicated by
synaptophysin-positive neuronal cells and vessels lined with CD31 expressing endothelial cells.
Ex vivo organ bath studies demonstrated that regenerated tissues supported by both silk matrices
displayed contractile responses to carbachol, α,β-methylene-ATP, KCl, and electrical field
stimulation similar to controls. Our data detail the ability of acellular silk scaffolds to support
regeneration of innervated, vascularized smooth muscle and urothelial tissues within 3 m with
structural, mechanical, and functional properties comparable to native tissue in a porcine model of
bladder repair.
Keywords
silk; tissue engineering; bladder; wound healing
1. Introduction
Enterocystoplasty is the primary surgical procedure utilized to reduce urinary storage
pressures and reduce the risk of renal damage and incontinence associated with a variety of
congenital and acquired bladder pathologies including neurogenic bladder, bladder
exstrophy, and posterior urethral valves [1,2]. Transposition of gastrointestinal segments
into the urinary tract leads to a number of significant complications including chronic
urinary tract infection, metabolic abnormalities, secondary malignancies, as well as donor
site morbidity [3,4], all of which can compromise the efficacy of the treatment and adversely
affect the patient’s quality of life. Short-term clinical studies of bladder tissue engineering
have investigated both natural and synthetic scaffolds either alone or seeded with autologous
bladder cell populations as alternative strategies for defect repair or neobladder
reconstruction [5,6]. In particular, Atala et al. first demonstrated the ability of a
biodegradable, collagen-coated poly-glycolic acid (PGA) mesh, seeded with autologous
cells expanded ex vivo, to mediate de novo bladder tissue formation in children afflicted
with myelomeningocele [5]. However, bladder compliance and capacity failed to increase in
the majority of subjects to a clinically relevant degree potentially compromising the long-
term effectiveness of this approach to mitigate the high intravesical pressures routinely
encountered in this patient population [7].
Previous reports have demonstrated that incorporation of autologous primary cells into
scaffolds prior to implantation enhances the ability of tissue engineered constructs to
mediate bladder tissue repair [8–10]. However this strategy harbors practical and technical
concerns which may hamper its widespread clinical deployment. First, the use of patient-
derived cells requires secondary surgical procedures for tissue isolation and propagation of
in vitro cultures [5], thereby requiring substantial laboratory resources to attain sufficient
cell numbers for implant seeding. In addition, urothelial and smooth muscle cells are subject
to de-differentiation during in vitro cultivation [11,12], potentially compromising the in vivo
performance of seeded constructs. Moreover, autologous cells isolated from diseased
bladders have been shown to display various functional abnormalities [13,14] and therefore
may not be suitable for restoration of normal organ operations. The risk of pathogen
acquisition prior to re-implantation is also a significant safety concern associated with this
approach [15]. Recent clinical trials deploying decellularized small intestinal submucosa
(SIS) grafts for augmentation cystoplasty in exstrophy patients sought to overcome
limitations associated with cell-seeded approaches for bladder reconstruction [6]. However,
implantation of acellular SIS matrices failed to establish long-term urinary continence and
did not support significant increases in bladder capacity and compliance as well as
regeneration of normal smooth muscle architecture. Therefore, there is a significant need to
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develop alternative, acellular biomaterial configurations with the capacity to promote
functional bladder tissue regeneration.
Biomaterials derived from Bombyx mori silkworm cocoons exhibit a unique set of
properties including high structural strength and elasticity [16], diverse processing plasticity
[17], and tunable biodegradability [18] which make them particularly suited for the repair of
hollow organ defects. Previous studies in rodent models of augmentation cystoplasty have
demonstrated that acellular silk scaffolds display particular advantages in comparison to
conventional PGA and SIS scaffolds including improved functional performance, enhanced
tissue regeneration, and minimal inflammatory reactions [19,20]. In particular, a bi-layer
scaffold configuration, comprised of a porous silk foam buttressed by a nonpermeable silk
layer, supported the formation of innervated, vascularized bladder tissue while promoting
significant increases in bladder capacity and compliance [20]. In the current study, we
investigated the ability of acellular bi-layer silk scaffolds to mediate tissue regeneration in a
porcine model of bladder augmentation.
2. Materials and Methods
2.1. Biomaterials
Aqueous silk fibroin solutions were prepared from B. mori silkworm cocoons [16] and
utilized to construct two bi-layer matrix configurations using methods previously described
[16,20]. For Group 1 matrices, a 6% wt/vol silk fibroin solution was mixed with sieved
granular NaCl (500–600 µM, average crystal size) in a ratio of 2 g NaCl per ml of silk
solution and cast within a rectangular vessel for 48 h at 37°C. Group 2 scaffolds were
produced similarly; however the NaCl/silk solution was layered on to a silk film which was
generated first by drying a 8% wt/vol silk solution within the casting vessel for 48 h at room
temperature under a laminar flow hood. NaCl was subsequently removed from both matrix
variants by washing the scaffolds for 72 h in distilled water with regular volume changes.
Scaffold groups were then autoclave sterilized and subjected to analytical or surgical
procedures described below.
2.2. Scanning electron microscopy (SEM)
Structural analysis of matrix groups prior to implantation was performed in order to assess
differences in scaffold morphology generated by various fabrication techniques. Matrix
samples were sputter coated with Pt/Pd and imaged using a Zeiss scanning electron
microscope, model EVO MA10 (Carl Zeiss AG, Germany).
2.3. Porcine augmentation cystoplasty
Bladder augmentation was performed in 10 juvenile female Yorkshire swine (3 m of age)
following IACUC-approved protocols. Three additional pigs served as longitudinal controls
receiving no surgical intervention. Open and robotic-assisted laparoscopic augmentation
cystoplasty were utilized for scaffold implantation in independent animals in order to verify
the efficacy of the bi-layer scaffolds to be used in both traditional open and minimally-
invasive laparoscopic surgical procedures. Both surgical approaches were performed under
sterile technique with maintenance anesthesia using 2–3% isoflurane following induction
with intramuscular injection of 0.4mg/kg atropine, 2.2mg/kg xylazine, and 4.4mg/kg
tiletamine+zolazepam. All pigs were mechanically ventilated for the duration of the
operative procedures.
Augmentation cystoplasty was performed via a hand-assisted robotic approach (Group 1:
N=2) as previously described [21]. Briefly, the dome of the bladder was incised
longitudinally, and a 6×6cm2 scaffold was introduced via a hand port and anastomosed to
Tu et al. Page 3
Biomaterials. Author manuscript; available in PMC 2014 November 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
the bladder defect using a 3-0 polyglactin suture in a running fashion. Marking sutures were
placed at all 4 corners of the scaffold with a 4-0 polypropylene nonabsorbable suture. Open
augmentation cystoplasty was also performed (Group 1: N=4; Group 2: N=4) as previously
described [22]. Briefly, a lower abdominal midline incision was made and carried down
through the peritoneum to expose the bladder. The bladder dome was opened longitudinally
and scaffolds (6×6cm2) were anastomosed and bordered by marking sutures as described for
the robotic technique. For both surgical approaches, a urethral catheter was advanced into
the bladder lumen and secured to the perineum. Organ distension via the urethral catheter
was performed with saline infusion following scaffold integration to ensure no gross leaks
were present through the scaffold center or along the suture line. Rectus abdominis fascia
and skin incisions were subsequently closed with running sutures. The urethral catheter was
left free to drainage for 7 d post-implantation in all augmented animals. Following catheter
removal, animals were allowed to void voluntarily. All animals were kept on prophylactic
antibiotics (3.3 mg/kg/d nitrofurantoin) for 8 d post-operatively. Urethral recatheterization
and additional antibiotic treatment of two animals implanted with Group 1 scaffolds was
performed respectively at 1 m and 2 m post-operatively for 2 wk due to the presence of low-
grade fevers. After this period, catheters were removed and animals were allowed to void
voluntarily until the completion of the study. Analysis of serum creatinine levels was
performed in all animals pre-operatively and at 1, 2, 3 m post-operatively. Nonsurgical
controls and swine receiving implants were euthanized at 3 m post-implantation and isolated
bladder specimens were subjected to contractile, histological and immunohistochemical, and
mechanical analyses.
2.3. Urodynamics
Bladder compliance and capacity were determined pre-operatively and at 3 m post-
implantation under anesthesia. Longitudinal nonsurgical swine were evaluated in parallel
upon arrival into the animal housing facility and following 3 m of boarding. Briefly, a 12
French urethral catheter was inserted into the bladder and attached to two 3-way stopcocks
arranged in series. One stopcock was attached to a glass manometer which was maintained
level with the animal’s bladder and the other was used for instillation of contrast agent
(Optiray™, Hazelwood, MO) at 37°C. Stepwise cystometry was performed as previously
described [23] wherein intravesical pressure measurements were recorded at 50 ml
increments up to 1650 ml instilled volume. Bladder capacity and cystogram images were
recorded at a fill volume exerting ~20 cmH2O pressure to avoid organ rupture or
vesicoureteral reflux. Bladder compliance was determined by calculating Δvolume/
Δpressure between ~10–20 cmH2O during cystometry.
2.4. Mechanical testing
Uniaxial tensile tests were performed as previously described [24] on an Instron 3366 testing
frame (Norwood, MA) equipped with a 100 N capacity load cell and Biopuls pneumatic
clamps. Scaffold specimens prior to implantation (N=4 per group) as well as regenerated (3
m post-operatively) and control tissues harvested from the bladder dome (N=3–4 per group)
were hydrated in phosphate buffered saline (PBS) at least 3 h to reach a swelling equilibrium
prior to testing. Test samples were submerged in a temperature-controlled testing container
(Biopuls) filled with PBS at 37°C. A displacement control mode with a crosshead
displacement rate of 1.8 mm/min was used, and the gauge length was 10 mm. The initial
elastic modulus (EM), ultimate tensile strength (UTS) and % elongation to failure (ETF)
were calculated from stress/strain plots. EM was calculated by using a least-squares (LS) fit
within the linear elastic region. UTS was determined as the highest stress value attained
during the test and the ETF was the last data point before a >10% decrease in the load. Data
were presented as mean ± standard deviation.
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2.5. Histological and immunohistochemical analyses
Regenerated and control tissue segments from both the periphery and central regions of the
bladder dome were excised for standard histological processing. Briefly, specimens were
fixed in 10% neutral-buffered formalin, dehydrated in graded alcohols, and then embedded
in paraffin. Sections (10 µm) were cut and then stained with hematoxylin and eosin (H&E).
For immunohistochemical (IHC) analyses, contractile smooth muscle markers such as α-
smooth muscle actin (α-SMA) and SM22α; urothelial-associated protein, uroplakin (UP),
cytokeratins (CK), and p63; neuronal and endothelial markers, synaptophysin (SYP38) and
CD31, respectively, were detected using the following primary antibodies: anti-α-SMA
[Sigma-Aldrich, St. Louis, MO, cat.# A2457, 1:200 dilution], anti-SM22α [Abcam,
Cambridge, MA, cat.# ab14106, 1:200 dilution], anti-pan-UP [rabbit antisera raised against
total bovine UP extracts, 1:100 dilution], anti-pan-CK [Dako, Carpinteria, CA, cat.# M3515,
1:200 dilution], anti-p63 [Santa Cruz Biotechnology, Santa Cruz, CA, cat.# sc-8431, 1:200
dilution], anti-SYP38 [Abcam, cat.# ab8049, 1:200 dilution], anti-CD31 [Abcam, cat.#
ab228364, 1:100 dilution]. Sections were then incubated with species-matched Cy3-
conjugated secondary antibodies (Millipore, Billerica, MA) and nuclei were counterstained
with 4’, 6-diamidino-2-phenyllindole (DAPI). Specimens were visualized using an
Axioplan-2 microscope (Carl Zeiss MicroImaging, Thornwood, NY) and representative
images were acquired using Axiovision software (version 4.8).
2.6. Ex vivo contractility
Regenerated tissue segments harvested from the central bladder dome of the original defect
site as well as native tissues extracted from similar regions of longitudinal controls were
subjected to ex vivo organ bath contractility analyses as previously described [25]. Briefly,
bladder tissue strips either intact or separated from mucosa were suspended in an organ bath
maintained at 37°C and bubbled with a mixture of 95% O2 and 5% CO2. Tissues were
attached to a force transducer (Grass Instruments), stretched to a resting tension of 2 g and
equilibrated for 45 min. Contractile responses to carbachol (cholinergic agonist, 1 nM–10
µM), α,β-methylene (me)-ATP (purinergic agonist, 10 µM), KCl (120 mM), and to electrical
field stimulation (EFS) (1–64 Hz, 20 V, 0.5 ms pulse width, 10 sec duration) were
measured. Conditioned signals from force transducers were continuously acquired at 30 Hz
by a 16-channel analog-to-digital converter (DataQ, DI-720) and recorded to disk using
Windaq data acquisition software. Data were expressed as force (mN) normalized by tissue
cross-sectional area and presented as mean ± standard deviation.
2.6. Statistical analyses
Tensile testing and contractility measurements were analyzed with the Mann-Whitney U test
using SPSS Statistics software v19.0 (www.spss.com). Statistically significant values were
defined as p<0.05.
3. Results and Discussion
SEM analyses of scaffold groups (Figure 1A) revealed the formation of a bi-layer structure
with distinct structural compartments. The solvent-cast/NaCl-leached layer comprised the
bulk of each scaffold variant and resembled a foam configuration with large pores (pore
size, ~400µm) interconnected by a network of smaller pores dispersed along their periphery.
Group 1 scaffolds displayed spontaneous pore occlusion of the solvent-cast/NaCl-leached
layer along the plane adjacent to the casting vessel; however continuity of this feature was
heterogeneous along the surface area with pockets of porous channels. In contrast, Group 2
matrices were buttressed by a homogenous, non porous silk film (200µm thick) generated by
the annealing of dehydrated silk solutions during casting.
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Tensile testing of matrix groups prior to implantation (Figure 1B) revealed that Group 2
scaffolds displayed significantly higher UTS (2.4-fold) and EM (3.6-fold) in comparison to
Group 1. These features suggest that the presence of the annealed silk film in Group 2
matrices acted to reinforce the foam compartment, therefore substantially increasing global
construct mechanical integrity. However, ETF values were found to be similar between the
two matrix configurations regardless of the presence of the annealed silk film therefore
providing evidence that the overall flexibility of the bi-layer scaffolds is primarily
influenced by the properties of the foam compartment. Indeed, comparisons between ETF of
Group 2 scaffolds (44%) and a similar matrix variant (197%) previously utilized for rat
bladder augmentation [20], wherein the foam compartment was considerably thinner (33%
of Group 2), but with a comparable film layer, revealed an inverse correlation between
overall construct ETF and foam compartment thickness. Taken together, these results
highlight the contribution of each scaffold layer to overall construct tensile properties.
Robot-assisted laparoscopic and open augmentation cystoplasty were both feasible
approaches for surgical integration of bi-layer silk scaffolds into bladder defects (Figure
2A–C). Over the course of the 3 m implantation period, the survival rate of augmented
animals receiving Group 1 or 2 scaffolds was 83% (5/6) and 100% (4/4), respectively, prior
to scheduled euthanasia. Exploratory laparotomy following the one animal death occurring
in Group 1 at 2 d post-op revealed urinary ascites as the probable cause of death. Despite
leak testing immediately following bladder integration, prominent fluid leaks throughout the
center of the scaffold were observed during post-mortem saline instillation of the augmented
bladder. The inability of this Group 1 replicate to support integrity of the defect site was
presumably due to unstable pore occlusion of the bulk foam matrix following implantation.
In contrast, no signs or symptoms of urinary ascites were seen over the course of the study
period in any of the animals implanted with Group 2 scaffolds. This observation suggests
that the annealed silk film compartment in the Group 2 matrix configuration confers a
particular advantage in maintaining defect consolidation over Group 1 scaffolds as a whole.
Urodynamic studies (Figure 3A) showed a wide extent of pre-operative bladder capacities
(range, 250–1050 ml; median, 425 ml) in all subjects analyzed (12/13) independent of initial
animal weight (mean, 37.2 ± 3.3 kg). Non surgical longitudinal controls demonstrated
substantial elevations in bladder capacity (144%) and overall weight (41%) following the 3
m study period, consistent with juvenile animal growth. Swine implanted with Group 1 or 2
matrices exhibited similar increases in overall weight (Group 1: 40%; Group 2: 33%);
however at 3 m post-op, respective gains in bladder capacity were substantially higher in
comparison to controls with levels of 277% and 153% over baseline. Qualitative expansion
of bladder size following 3 m post-op was confirmed by cystography in subjects implanted
with both silk groups (Figure 3B). No evidence of contrast extravasation in the reconstructed
organs was noted.
In contrast to bladder capacity, pre-operative bladder compliance for all animals investigated
(12/13) was similar with a mean value of 34 ± 6 ml/cmH2O. Longitudinal controls displayed
a 41% increase in bladder compliance following 3 m of housing consistent with published
observations showing a positive correlation between this parameter and growth during
juvenile stages of development [26]. In comparison to compliance gains in controls, animals
implanted with both matrix configurations demonstrated considerably higher mean
differentials over baseline levels with increases of 357% and 147% in Groups 1 and 2,
respectively. These results are consistent with our previous urodynamic study in rats
wherein a 10-fold increase in organ compliance was observed following bladder
augmentation with bi-layer silk scaffolds [20]. Interestingly, augmentation cystoplasty in
this rodent model with SIS or structurally-divergent gel spun silk scaffolds led to modest
1.5-fold increases in this parameter. Collectively, these data demonstrate that regenerative
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processes supported by bi-layer silk scaffolds selectively promote increases in organ
compliance in both small and large animal models of bladder repair. This feature is
potentially advantageous for clinical bladder reconstruction since increases in bladder
compliance are desired in patients afflicted with neurogenic bladder or exstrophy which
often display reduced levels of this parameter [27] elevating the risk for high intravesical
pressures and subsequent renal damage.
Following 3 m post-op, gross tissue evaluations of the upper urinary tract revealed no signs
of hydronephrosis or renal anomalies in controls or animals implanted with either silk matrix
configuration. These results are consistent with the lack of significant alterations in serum
creatinine levels in all experimental groups over the course of the study (data not shown)
suggestive of normal kidney function. In all augmented bladders, extensive host tissue
ingrowth spanned the entire area of the original implantation site with a midline scar
apparent in each regenerated tissue which was more prominent in Group 2 subjects (Figure
4A, B). Negligible contraction between the anterior to posterior lengths of the original
implanted areas was observed between the marking sutures following defect consolidation
with both scaffold types. In contrast, prominent lateral contraction was noted in all
implantation sites regardless of the matrix configuration utilized. Tensile testing (Figure 4C)
revealed that the regenerated tissues in both implant groups displayed UTS similar to
controls. However, the EM of the consolidated tissues from Group 1 and 2 was elevated in
comparison to native levels by 1.6-fold and 3-fold, respectively, indicating an increase in
stiffness. In addition, implantation of Group 1 and 2 scaffolds led to de novo tissue
formation which exhibited respective ETF values which were 80% and 46% of control
levels.
In 3/4 animals augmented with Group 2 scaffolds, intravesical urinary calculi were observed
(Figure 4B, insert) which varied in appearance from encrusted films reminiscent of annealed
silk layers utilized during scaffold construction to soft, amorphous sedimentous debris.
Analysis of all Group 2 calculi revealed a calcium carbonate/calcium phosphate (95/5%)
composition. In subjects implanted with Group 1 matrices, stone formation was minimal and
specific to only 1/5 animals with a composition similar to those observed in Group 2. The
increase in stone formation in swine implanted with Group 2 matrices is presumably due to
the relatively slow degradation kinetics of the annealed silk film layer in comparison to the
bulk foam compartment. Indeed, our previous study in rodents demonstrated that nonporous
silk films comprising bi-layer silk scaffolds remained largely intact and were a nidus for
stone formation following bladder augmentation [20]. These results are consistent with other
published studies which demonstrate the extent of scaffold porosity is a significant factor in
determining the rate of degradation presumably due to more efficient exposure of the matrix
interior to proteolytic enzymes and subsequent polymer hydrolysis [18,24]. Future scaffold
optimization studies will focus on increasing the rate of in vivo degradation of annealed silk
films through pre-treatment with proteolytic enzymes prior to implantation; an approach
previously shown to enhance degradation kinetics [28].
Global histological examinations (H&E analysis) at 3 m post-op revealed that in both
experimental groups there was extensive ingrowth of connective tissue from the host bladder
wall into both the radial peripheral and central regions of the original implantation sites
(Figure 5). In addition, cross-sectional organization throughout the de novo bladder wall in
each augmented group resembled native control tissue architecture with distinct
compartments consisting of a lumenal epithelium, an extra-cellular matrix (ECM)-rich
lamina propria, and an outer layer of smooth muscle bundles. H&E analysis also revealed
discrete regions of mild fibrosis dispersed throughout the central and radial peripheral
regions of all regenerated tissues with exception of the midline scar area present in both
groups wherein moderate levels of fibrosis were detected (data not shown). Throughout all
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regenerated tissues supported by both scaffold groups, discrete areas of chronic
inflammatory reactions were observed with mobilized follicular aggregates of mononuclear
cell infiltrates. Similarly, minimal acute inflammatory reactions characterized by the
presence of occasional eosinophil granulocytes were also noted (data not shown). These
immunogenic responses are similar to those previously observed in rodent models of bladder
augmentation with silk biomaterials [24]. In addition, extensive fragmentation of the porous
compartment of both scaffold configurations was noted within the regenerated lamina
propria with qualitatively higher levels of residual scaffold remnants present within the
central bladder wall in comparison to the radial peripheral areas. These data suggest that
degradation of the bi-layer scaffolds proceeded in a radial fashion from the border of the
original implantation site toward the center regions as host tissue integration proceeded.
IHC assessments revealed that the reconstituted smooth muscle layers in both experimental
groups stained positive for α-SMA and SM22α contractile protein expression to similar
extents as those observed in control specimens indicating prominent smooth muscle
maturation (Figure 6A). A cytokeratin-positive, multi-layer urothelium was also present
within both radial peripheral and central regions of the regenerated tissues supported by each
matrix configuration (Figure 6B). The transitional nature of the urothelium was confirmed in
all regenerated tissues by IHC analysis wherein p63-positive basal and intermediate cell
layers were lined with lumenal p63-negative superficial cells. Varying degrees of
hyperplasia were observed in the basal and intermediate cell compartments supported by
Group 2 scaffolds in comparison to controls. This feature may reflect incomplete urothelial
maturation since normalization of basal/intermediate cell proliferation is required during
wound healing for native tissue stratification to be achieved [24,29]. Regenerated tissues
supported by both scaffold types displayed robust UP expression in both superficial and
intermediate cell layers to levels similar to those observed in control tissues. Expression and
assembly of UP into heterodimers which form asymmetrical unit membranes is essential for
maintaining the integrity of the urothelial permeability barrier [30].
Evidence of de novo vascularization and innervation processes were observed throughout all
regenerated tissues supported by each implant group (Figure 6C). Vessels containing
prominent CD31 positive endothelial cells were found in both the radial periphery and
central implantation sites while neuronal lineages displaying SYP38 indicative of synaptic
transmission areas were localized throughout the de novo bladder wall. These results
demonstrate that silk scaffold configurations described in this study are capable of
supporting regeneration of innervated, vascularized smooth muscle and urothelial tissues in
a large animal model of bladder repair.
Detrusor smooth muscle contractility is an integral process mediating voiding function in the
bladder. Contractility analyses of isolated bladder muscle strips were performed to ascertain
the ability of the scaffold groups to support functional regeneration. Carbachol-induced
contractile responses in denuded bladder strips demonstrated statistically similar extents of
tensile force in tissues from both augmented groups in comparison to control levels over all
steady-state drug concentrations examined (Figure 7A). These data suggest that the
regenerated smooth muscle displays muscarinic receptor-mediated contractile responses
since carbachol is a known agonist of muscarinic receptors which have been reported to
mediate bladder contraction in swine [31]. Comparisons between regenerated bladders strips
with intact mucosa from both augmented groups and their denuded counterparts showed a
significant reduction in tensile force in response to carbachol stimulation (data not shown).
This feature is consistent with published reports demonstrating an inhibitory effect of the
mucosa on carbachol-induced contraction of porcine bladder smooth muscle [32] and
therefore shows the regenerated mucosa from both implant groups displayed this type of
bioactivity.
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Contractile responses to nerve stimulation following EFS [33] were also observed in
denuded bladder strips from both control and regenerated tissues indicating functional
innervation in the augmented groups (Figure 7B). However, EFS (2–32 Hz) produced
significantly reduced levels of tensile force in Group 2 bladder strips in comparison to
controls while Group 1 specimens responded similarly to native tissue across all frequencies
tested. Induction of smooth muscle contractility by KCl-mediated membrane depolarization
demonstrated similar degrees of tensile force generated by regenerated tissues from both
implants groups in comparison to control levels (Figure 7C), indicating the integrity of the
contractile apparatus in regenerated tissues. In addition, the generation of tensile forces
following α,β-methylene-ATP stimulation in de novo tissues supported by each scaffold
group provides evidence for postsynaptic purinoceptor activation and contractility responses
following tissue regeneration (Figure 7D). Collectively, these data show that silk scaffolds
support regeneration of bladder smooth muscle tissue with contractile properties in a porcine
defect model.
4. Conclusions
The results presented in this study detail the ability of acellular silk scaffolds to support
regeneration of innervated, vascularized smooth muscle and urothelial tissues with
structural, mechanical, and functional properties comparable to native controls in a porcine
model of bladder repair. In addition, our data show implantation of these matrices promoted
gains in bladder capacity and compliance over pre-operative and control levels as well as
voluntary animal voiding. Performance comparisons between silk matrix configurations
demonstrate that reinforcement of porous silk foams with annealed silk films present in
Group 2 scaffolds increases overall matrix UTS and EM and enhances animal survival by
reducing the incidence of organ leakage following defect consolidation. Optimization of silk
film layers in Group 2 matrices through modulation of fabrication procedures will be a
future goal in order to reduce the incidence of stone formation and translation potential of
this scaffold technology toward clinical applications. In addition, verification of the efficacy
of silk matrices to recapitulate the results of this study in animal models of bladder disease is
a requirement before patient deployment will be considered. In any event, this report
provides a foundation for further investigations into the potential of silk scaffolds for
functional tissue engineering of clinical-scale urinary tract defects.
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Figure 1.
Structural and mechanical analyses of scaffold groups. [A] Photomicrographs of
representative SEM images demonstrating cross-sectional and top views of matrix
configurations. Scale bar = 400 µm. Inset: gross view of Group 2 scaffold prior to
implantation. Scale bar = 4 cm. [B] Evaluation of ultimate tensile strength (UTS), elastic
modulus (EM), and % elongation to failure (ETF) in matrix groups defined in [A]. Means ±
standard deviation per data point. (*) = p<0.05 in comparison to Group 1.
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Figure 2.
Porcine augmentation cystoplasty models. Photomicrographs of [A] robot-assisted
laparoscopic and [B–C] open approaches for bladder augmentation with matrix groups. For
all panels, scale bars = 2 cm.
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Figure 3.
Animal weight and urodynamic assessments of longitudinal controls and swine augmented
with each scaffold group. [A] Table of animal weight, bladder capacity and compliance both
pre-operatively and following 3 m of matrix implantation. D = animal death prior to
scheduled evaluation; NP = evaluation not performed; ND = not determined. [B]
Photomicrographs of cystograms of swine described in [A]. Scale bar = 6 cm.
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Figure 4.
Gross morphological evaluations and tensile properties of regenerated tissues supported by
scaffold groups. [A] Photomicrographs of the luminal plane of de novo tissue excised from
the original scaffold integration site following 3 m of implantation. (S) denotes midline scar.
Scale bar = 3 cm. Inset: urinary calculi. Scale bar = 3 cm. [B] Evaluation of ultimate tensile
strength (UTS), elastic modulus (EM), and % elongation to failure (ETF) in regenerated
tissues defined in [A] as well as nonsurgical control bladder specimens. Means ± standard
deviation per data point. (*) = p<0.05 in comparison to respective control measurements.
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Figure 5.
Cross-sectional histological evaluations (H&E analysis) of radial periphery and central
regions of both control and regenerated bladder domes supported by scaffold groups
following 3 m of implantation. UE = urothelium; LP = lamina propria; SM = smooth
muscle; SC = residual silk scaffold. (*) = aggregates of mononuclear cell infiltrates. Scale
bars for 1st row, 800 µm; 2nd–3rd rows, 400 µm; inset, 100 µm.
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Figure 6.
Immunohistochemical (IHC) assessments of tissue regeneration of radial periphery and
central regions of both control and regenerated bladder domes supported by scaffold groups
following 3 m of implantation. Photomicrographs of protein expression of [A] contractile
markers (α-SMA and SM22α); [B] urothelial-associated markers, uroplakin (UP), p63,
cytokeratins (CK); [C] endothelial marker, CD31; and innervation marker, synaptophysin
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(SYP38). For [A], SM denotes smooth muscle. For [B] arrows denote p63-positive basal
and/or intermediate urothelial cells (yellow); p63-negative superficial urothelial cells
(white). For [C], V denotes vessels in top row and white arrows denote neurons in bottom
row. For all panels, respective marker expression is displayed in red (Cy3 labeling) and blue
denotes DAPI nuclear counterstain. Scale bars in all panels = 200 µm.
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Figure 7.
Ex vivo contractility evaluations of central regions of both control and regenerated bladder
domes supported by scaffold groups following 3 m of implantation. [A] Dose-response
curves for carbachol in denuded bladder strips. [B] Frequency response curves for electrical
field stimulation (EFS) in specimens described in [A]. (*) = p<0.05 in comparison to
respective control measurements. Contractile responses to [C] increased extracellular KCl
(120 mM) and [D] α-β-methylene-ATP (10 µM) in samples detailed in [A].
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